首頁 › 帕金森氏症 › 堪薩斯 › Kansas City
Kansas City, KS 的 帕金森氏症 臨床試驗
8 項針對 帕金森氏症 的研究正在 Kansas City（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
招募中2 期
- University of Kansas Medical Center, Kansas City
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
招募中2/3 期
- Site-029, Kansas City
A Study of Buntanetap in Participants With PD
招募中2/3 期
- University of Kansas Medical Center (KUMC) - School of Medicine - Parkinson's Disease and Movement D, Kansas City
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
招募中2 期
- The University of Kansas (KU) (Site #216), Kansas City
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
招募中3 期
- University of Kansas Medical Center, Kansas City
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
招募中3 期
- University of Kansas Medical Center, Kansas City
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
招募中觀察性研究歡迎健康志工
- University of Kansas Medical Center, Kansas City
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
招募中4 期
- University of Kansas Medical Center, Kansas City
其他城市的 帕金森氏症 試驗
- New York City, NY23 項研究
- Boston, MA19 項研究
- Cleveland, OH18 項研究
- Minneapolis, MN17 項研究
- Nashville, TN15 項研究
- Philadelphia, PA14 項研究
- San Francisco, CA14 項研究
- New Haven, CT14 項研究
- Charleston, SC13 項研究
- Farmington Hills, MI13 項研究
- Chicago, IL13 項研究
- Miami, FL13 項研究
Kansas City 的其他研究
- 心血管疾病14 項研究
- 心臟衰竭13 項研究
- 肥胖症13 項研究
- 間質性肺病13 項研究
- 囊腫性纖維化13 項研究
- 乳癌12 項研究
- 膀胱癌12 項研究
- 急性髓系白血病12 項研究
- 前列腺癌12 項研究
- 非小細胞肺癌11 項研究
- 肺癌11 項研究
- 慢性阻塞性肺病9 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。